3Burns A, Byme E J, Maurer K. Alzheimer's disease[J]. Lancet,2002(360): 163-165.
4Selkoe D J. Alzheimer' s disease:genes, proteins and therapy[J ]. Physiol Rev. 2001 (81) : 741-766.
5Cruz L, Urbane B, Buldyrev S V, et al. Aggregation and disaggregation of senile plaques in Alzheimer disease[J]. Proc. Natl. Aead. Sci.USA, 1997(94) : 7 612-7 616.
6Pierrat C S, Abramowski D, Duke M. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology[J].Proc. Natl. Acad. Sci. USA, 1997(94) : 13 287-13 292.
7Kuo Y M, Kokjohn T A, Beach T G. Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains[J]. J. Biol. Chem. ,2001(276): 12 991-12 998.
8Moil H, Takio K, Ogawara M. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease[J]. J. Biol. Clacm. , 1992(267) :17 082-17 086.
9Multhaup G, Scheuermann S, Schlicksupp A, et al. Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disense[J]. Free Rad. Biol. Med, 2002 (33) : 45-51.
10Lewis J, Dickson D W, Lin W L, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP[J]. Science,2001 (293) : 1 487-1491.
